EGFR Targeting TKI-Related Skin Toxicities in a Patient with Darker Skin: A Case Report

Epidermal growth factor receptor (EGFR) targeting tyrosine kinase inhibitors (TKIs) can result in significant skin toxicities that may impact patients’ quality of life. While these skin reactions are well documented in patients with lighter skin, there is a paucity of literature and images to guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zereshkian, Arman, Thawer, Alia, Hwang, David M., Cheng, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028593/
https://www.ncbi.nlm.nih.gov/pubmed/35448179
http://dx.doi.org/10.3390/curroncol29040205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028593/
https://www.ncbi.nlm.nih.gov/pubmed/35448179
http://dx.doi.org/10.3390/curroncol29040205

Ejemplares similares